PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30914801-1	2019	Farnesyl diphosphate synthase (FDPS), a mevalonate pathway enzyme, is highly expressed in several cancers, including prostate cancer (PCa).	Mevalonic Acid	40-50	farnesyl diphosphate synthetase	Mus musculus	0-29	
30914801-1	2019	Farnesyl diphosphate synthase (FDPS), a mevalonate pathway enzyme, is highly expressed in several cancers, including prostate cancer (PCa).	Mevalonic Acid	40-50	farnesyl diphosphate synthetase	Mus musculus	31-35	
30914801-9	2019	Pharmacological targeting of FDPS by zoledronic acid (ZOL), which is already in clinics, exhibit reduced growth and clonogenicity of human and murine PCa cells (P < 0.01) and 3D tumoroids (P < 0.02) by disrupting AKT and ERK signaling through direct interference of small GTPases protein prenylation.	Zoledronic Acid	37-52	farnesyl diphosphate synthase	Homo sapiens	29-33	
30914801-9	2019	Pharmacological targeting of FDPS by zoledronic acid (ZOL), which is already in clinics, exhibit reduced growth and clonogenicity of human and murine PCa cells (P < 0.01) and 3D tumoroids (P < 0.02) by disrupting AKT and ERK signaling through direct interference of small GTPases protein prenylation.	Zoledronic Acid	37-52	thymoma viral proto-oncogene 1	Mus musculus	213-216	
30914801-9	2019	Pharmacological targeting of FDPS by zoledronic acid (ZOL), which is already in clinics, exhibit reduced growth and clonogenicity of human and murine PCa cells (P < 0.01) and 3D tumoroids (P < 0.02) by disrupting AKT and ERK signaling through direct interference of small GTPases protein prenylation.	Zoledronic Acid	37-52	mitogen-activated protein kinase 1	Mus musculus	221-224	
30914801-9	2019	Pharmacological targeting of FDPS by zoledronic acid (ZOL), which is already in clinics, exhibit reduced growth and clonogenicity of human and murine PCa cells (P < 0.01) and 3D tumoroids (P < 0.02) by disrupting AKT and ERK signaling through direct interference of small GTPases protein prenylation.	Zoledronic Acid	54-57	farnesyl diphosphate synthase	Homo sapiens	29-33	
30914801-9	2019	Pharmacological targeting of FDPS by zoledronic acid (ZOL), which is already in clinics, exhibit reduced growth and clonogenicity of human and murine PCa cells (P < 0.01) and 3D tumoroids (P < 0.02) by disrupting AKT and ERK signaling through direct interference of small GTPases protein prenylation.	Zoledronic Acid	54-57	thymoma viral proto-oncogene 1	Mus musculus	213-216	
30914801-9	2019	Pharmacological targeting of FDPS by zoledronic acid (ZOL), which is already in clinics, exhibit reduced growth and clonogenicity of human and murine PCa cells (P < 0.01) and 3D tumoroids (P < 0.02) by disrupting AKT and ERK signaling through direct interference of small GTPases protein prenylation.	Zoledronic Acid	54-57	mitogen-activated protein kinase 1	Mus musculus	221-224